Volume : 7, Issue : 2, February - 2018
EVALUATION OF REFRACTORY HEARTBORN ; IS IT
Dr. Sanjay Kumar, Dr Vinod Narkede, Dr Sandesh Sharma, Dr Pranav Raghuwanshi
Abstract :
<p> </p> <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;text-align: justify;text-justify:inter-ideograph;mso-layout-grid-align:none;text-autospace: none"><b style="mso-bidi-font-weight:normal"><span style="font-size:12.0pt; line-height:115%;font-family:"Times New Roman","serif"">Introduction:</span></b><span style="font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif""> Heartburn and non cardiac chest pain is a common symptom. It is known that excessive intraesophageal acid exposure causes the symptoms of retrosternal pain and burning. But many patients with chronic heartburn symptoms have no endoscopically or histologically discernible esophageal mucosal damage and many of them even do not have positive reflux as per 24-h pH monitoring.<o:p></o:p></span></p> <p class="MsoNormal" style="margin-bottom:7.5pt;text-align:justify;text-justify: inter-ideograph;background:white"><span style="font-size:12.0pt;line-height: 115%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman""><o:p> </o:p></span></p> <p class="MsoNormal" style="margin-bottom:7.5pt;text-align:justify;text-justify: inter-ideograph;background:white"><b><span style="font-size:12.0pt;line-height: 115%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">Methodology:</span></b><span style="font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif""> A retrospective study was carried out from July 2014 to July 2015. A total of 53 eligible study subjects (35 males, 18 females) [range 19 to 62 years] presented to OPD of gastrocare hospital were included. All study subjects who were having symptoms of Gastro Esophageal Reflux Disease, endoscopically negative, were not responding / partially responding to the standard dose of proton pup inhibitor were considered for 24–h esophageal pH monitoring ( after off PPI for 7 days). Acid contact time, Demeester score, symptom index and symptom associated probability was recorded.</span><b><span style="font-size: 12.0pt;line-height:115%;font-family:"Times New Roman","serif";mso-fareast-font-family: "Times New Roman""> </span></b><span style="font-size:12.0pt;line-height: 115%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman""><o:p></o:p></span></p> <p class="MsoNormal" style="margin-top:12.0pt;text-align:justify;text-justify: inter-ideograph"><b><span style="font-size:12.0pt;line-height:115%;font-family: "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">Results:</span></b><span style="font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman""> </span><span style="font-size: 12.0pt;line-height:115%;font-family:"Times New Roman","serif"">Out of 53 subjects 73.6% had heartburn and chest pain as their presenting complaints while 26.4 had other symptoms of GERD. 41.5% were having hypersensitive esophagus (HE), 22.6% had Nonerosive Reflux Disease (NERD), 18.9% had NERD with HE and 17% subjects had normal pH monitoring<o:p></o:p></span></p> <p class="MsoNormal" style="margin-bottom:7.5pt;text-align:justify;text-justify: inter-ideograph;background:white"><b><span style="font-size:12.0pt;line-height: 115%;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">Conclusion:</span></b><span style="font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif""> Unfortunately, not all available drugs (namely 5-HT3 antagonists and opioids), capable of reducing visceral<span style="mso-spacerun:yes"> </span>perception in the lower gastrointestinal tract, seem to be effective in the upper gastrointestinal tract. Therefore, reduction of the stimulus intensity (diet and PPI) remains at present the only alternative in clinical practice.</span><b><span style="font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman""> </span></b><span style="font-size:12.0pt;line-height:115%;font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman""><o:p></o:p></span></p>
Keywords :
Article:
Download PDF Journal DOI : 10.15373/2249555XCite This Article:
Dr. Sanjay Kumar, Dr Vinod Narkede, Dr Sandesh Sharma, Dr Pranav Raghuwanshi, EVALUATION OF REFRACTORY HEARTBORN ; IS IT , GLOBAL JOURNAL FOR RESEARCH ANALYSIS : VOLUME-7, ISSUE-2, FEBRUARY-2018


MENU
MENU